NovaBridge Biosciences (NBP) Return on Equity (2020 - 2025)

NovaBridge Biosciences (NBP) has 6 years of Return on Equity data on file, last reported at 0.0% in Q4 2025.

• Quarterly Return on Equity fell 1.0% year-over-year to 0.0% in Q4 2025, while the trailing twelve-month figure through Dec 2025 was 0.0% (down 1.0% YoY) and the FY2024 annual result came in at 0.0%, up 1.0% from the prior year.
• Return on Equity retreated to 0.0% in Q4 2025 per NBP's latest filing, from 0.0% in the prior quarter.
• Across five years, Return on Equity topped out at 0.0% in Q1 2025 and bottomed at 0.0% in Q4 2025.
• The 5-year median for Return on Equity is 0.0% (2025), against an average of 0.0%.
• The widest annual swing landed in 2021, when Return on Equity changed 0 bps; it then fell 1 bps in 2025.
• Tracing NBP's Return on Equity over 5 years: stood at 0.0% in 2021, then soared by 143 bps to 0.0% in 2022, then sank by 63 bps to 0.0% in 2023, then surged by 225 bps to 0.0% in 2024, then plunged by 222 bps to 0.0% in 2025.
• Per Business Quant, the three latest NBP Return on Equity figures stand at 0.0% (Q4 2025), 0.0% (Q3 2025), and 0.0% (Q2 2025).

Peer Comparison